Loading provider…
Loading provider…
Cardiovascular Disease Physician in Cincinnati, OH
NPI: 1447237342Primary Practice Location
CHRIST HOSPITAL
2139 Auburn Ave, Cincinnati, OH
Primary Employer
The Christ Hospital Cardiovascular Associates LLC
thechristhospital.com
HQ Phone
Get M.D. Peter's Phone Numberphone_androidMobile
Get M.D. Peter's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardOH State Medical License
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 93000Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 200 | 359 |
| 2 | 99214Established patient office or other outpatient visit, 30-39 minutes | 157 | 279 |
| 3 | 93306Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function | 82 | 83 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 76 | 164 |
| 5 | 99205New patient office or other outpatient visit, typically 60 minutes | 21 | 21 |
Authors: Robert Baughman, Francis Cordova, Elyse Lower
Journal: Chest
Authors: Aaron Waxman, Victor Tapson, Jeremy Feldman, Ricardo Restrepo-Jaramillo, Thenappan Thenappan, Abubakr Bajwa, Rahul Argula, Ashwin Ravichandran
Journal: Eur Respir J
Publication Date: 2023-06-29
Recommendations for the clinical management of patients receiving macitentan for pulmonary arterial hypertension (PAH): A Delphi consensus document.
Authors: Jeremy Feldman, Hassan Alnuaimat, Charles Burger, Namita Sood, Vijay Balasubramanian, Robert Bourge, Harold Palevsky
Publication Date: 2017-07-04
Lead Sponsor: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
Intervention / Treatment: DRUG: Placebo, OTHER: SOC, DRUG: Sotatercept
Lead Sponsor: Acceleron Pharma, Inc., a wholly-owned subsidiary of Merck & Co., Inc., Rahway, NJ USA
Intervention / Treatment: BIOLOGICAL: Sotatercept
Lead Sponsor: Aria CV, Inc
Intervention / Treatment: DEVICE: Aria CV Pulmonary Hypertension System